Nexus Announces Repricing of Warrants
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) has announced the repricing of 2,400,000 common share purchase warrants. The warrants, originally priced at $0.60 with an expiry date of April 30, 2026, will now have an exercise price of $0.36, effective immediately. This repricing is subject to the unanimous consent of the registered warrant holders and complies with Canadian Securities Exchange (CSE) policies.
The CSE requires that if the closing price of Nexus's common shares exceeds the new exercise price by more than 25% for any ten consecutive trading days, the expiry date of the repriced warrants must be amended to 30 days from the end of that period. Nexus will announce any such change via press release, with the 30-day period commencing seven days after the announcement.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) ha annunciato la rivalutazione di 2.400.000 warrant di acquisto di azioni ordinarie. I warrant, originariamente valutati a $0,60 con una data di scadenza del 30 aprile 2026, avranno ora un prezzo di esercizio di $0,36, con effetto immediato. Questa rivalutazione è soggetta al consenso unanime dei detentori registrati dei warrant e rispetta le politiche della Canadian Securities Exchange (CSE).
La CSE richiede che, se il prezzo di chiusura delle azioni ordinarie di Nexus supera il nuovo prezzo di esercizio di oltre il 25% per dieci giorni di trading consecutivi, la data di scadenza dei warrant rivalutati deve essere modificata in 30 giorni dalla fine di quel periodo. Nexus annuncerà eventuali cambiamenti tramite comunicato stampa, con il periodo di 30 giorni che inizia sette giorni dopo l'annuncio.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) ha anunciado la revalorización de 2,400,000 warrants de compra de acciones comunes. Los warrants, originalmente valorados en $0.60 con una fecha de vencimiento del 30 de abril de 2026, tendrán ahora un precio de ejercicio de $0.36, con efecto inmediato. Esta revalorización está sujeta al consentimiento unánime de los tenedores registrados de los warrants y cumple con las políticas de la Canadian Securities Exchange (CSE).
La CSE requiere que, si el precio de cierre de las acciones comunes de Nexus excede el nuevo precio de ejercicio en más del 25% durante diez días hábiles consecutivos, la fecha de vencimiento de los warrants revalorizados debe ser modificada a 30 días desde el final de ese período. Nexus anunciará cualquier cambio a través de un comunicado de prensa, con el periodo de 30 días comenzando siete días después del anuncio.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1)는 2,400,000개의 보통주 매수 권리증서의 가격 조정을 발표했습니다. 원래 $0.60에 가격이 매겨져 있었던 이 권리증서는 2026년 4월 30일 만료일을 두고 현재 발행 가격이 $0.36로 조정됩니다. 이 가격 조정은 등록된 권리증서 보유자의 만장일치 동의에 따르며 캐나다 증권 거래소(CSE) 정책을 준수합니다.
CSE는 Nexus의 보통주 종가가 새로운 발행 가격보다 25% 이상 초과하여 연속으로 10일 거래되는 경우, 재조정된 권리증서의 만료일을 해당 기간 종료일로부터 30일로 수정해야 한다고 요구합니다. Nexus는 이러한 변경 사항을 보도 자료를 통해 발표하며, 30일 기간은 발표 후 7일 뒤부터 시작됩니다.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) a annoncé la réévaluation de 2.400.000 bons de souscription d'actions ordinaires. Les bons, initialement évalués à 0,60 $ avec une date d'expiration du 30 avril 2026, auront maintenant un prix d'exercice de 0,36 $, avec effet immédiat. Cette réévaluation est soumise au consentement unanime des détenteurs enregistrés de bons et est conforme aux politiques de la Bourse canadienne des valeurs mobilières (CSE).
La CSE exige que si le prix de clôture des actions ordinaires de Nexus dépasse le nouveau prix d'exercice de plus de 25 % pendant dix jours de négociation consécutifs, la date d'expiration des bons réévalués doit être modifiée à 30 jours après la fin de cette période. Nexus annoncera tout changement via un communiqué de presse, le délai de 30 jours commençant sept jours après l'annonce.
Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) hat die Neubewertung von 2.400.000 Bezugsrechten auf Stammaktien bekannt gegeben. Die Bezugsrechte, die ursprünglich mit $0,60 bewertet waren und eine Verfallsfrist bis zum 30. April 2026 hatten, werden jetzt einen Ausübungspreis von $0,36 haben, mit sofortiger Wirkung. Diese Neubewertung unterliegt der einstimmigen Zustimmung der registrierten Bezugsrechtsinhaber und entspricht den Richtlinien der Canadian Securities Exchange (CSE).
Die CSE verlangt, dass, wenn der Schlusskurs der Stammaktien von Nexus den neuen Ausübungspreis um mehr als 25% an zehn aufeinanderfolgenden Handelstagen übersteigt, das Verfallsdatum der neubewerteten Bezugsrechte auf 30 Tage nach dem Ende dieses Zeitraums geändert werden muss. Nexus wird solche Änderungen über eine Pressemitteilung bekannt geben, wobei der 30-tägige Zeitraum sieben Tage nach der Ankündigung beginnt.
- Reduction of warrant exercise price from $0.60 to $0.36, potentially encouraging warrant exercise
- Compliance with CSE policies, ensuring regulatory adherence
- Potential dilution of existing shareholders if warrants are exercised at the lower price
- Risk of accelerated warrant expiration if stock price increases significantly
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2024) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) (the "Company" or "Nexus") announces the repricing of 2,400,000 common share purchase warrants with an exercise price of
As the Warrant Repricing will result in an exercise price lower than the market price of the Company's common shares on the date the warrants were issued, CSE policies require that, if following the Warrant Repricing, for any ten consecutive trading days the closing price of the Company's common shares on the CSE exceeds the amended exercise price by more than
About Nexus Uranium Corp.
Nexus Uranium Corp. is a multi-commodity development company focused on advancing the Cree East uranium project in the Athabasca Basin and the Wray Mesa uranium-vanadium project in Utah in addition to its precious metals portfolio that includes the Napoleon gold project in British Columbia, and a package of gold claims in the Yukon. The Cree East project is one of the largest projects within the Athabasca Basin of Saskatchewan spanning 57,752 hectares (142,708 acres) and has seen over
The technical content of this news release has been reviewed and approved by Warren D. Robb, P.Geo. (BC), a Director and VP Exploration of Nexus Uranium Corp. and a Qualified Person under National Instrument 43-101.
--
FOR FURTHER INFORMATION PLEASE CONTACT:
Jeremy Poirier
Chief Executive Officer
info@nexusuranium.com
This news release includes certain statements and information that may constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance are forward-looking statements and contain forward-looking information, including, but not limited to, completion of the Warrant Repricing. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this news release, including, but not limited to the assumption that the holders of the Repriced Warrants will consent to the Warrant Repricing. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including, but not limited to the risk that the holders of the Repriced Warrants will not consent to the Repricing, stock market volatility and capital market fluctuations, general market and industry conditions, as well as those risk factors discussed in the Company's most recently filed management's discussion & analysis. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227036
FAQ
What is the new exercise price for Nexus Uranium Corp's (GIDMF) repriced warrants?
How many warrants are affected by Nexus Uranium Corp's (GIDMF) repricing announcement?
When do the repriced warrants of Nexus Uranium Corp (GIDMF) expire?
Under what conditions would the expiry date of Nexus Uranium Corp's (GIDMF) repriced warrants change?
